Innate Pharma SA
PAR:IPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
PAR:IPH
|
FR |
|
Engro Corporation Ltd
SGX:S44
|
SG |
|
C
|
Charn Issara Development PCL
SET:CI
|
TH |
|
P
|
Philippine Stock Exchange Inc
XPHS:PSE
|
PH |
|
Enterprise Products Partners LP
NYSE:EPD
|
US |
|
I
|
IMCD NV
SWB:INX
|
NL |
|
Carr's Group PLC
LSE:CARR
|
UK |
|
W
|
WHA Corporation PCL
SET:WHA
|
TH |
|
B
|
BG Container Glass PCL
SET:BGC
|
TH |
|
Intracom Holdings SA
F:INTA
|
GR |
|
Diversified Energy Company PLC
LSE:DEC
|
US |
|
U
|
Utility Business Alliance PCL
SET:UBA
|
TH |
|
Strongpoint ASA
OSE:STRO
|
NO |
|
Ocean Plastics Co Ltd
TWSE:1321
|
TW |
|
Class Editori SpA
MIL:CLE
|
IT |
|
VR Resources Ltd
XTSX:VRR
|
CA |
|
DocMorris AG
SIX:DOCM
|
CH |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
VSE:VIG
|
AT |
|
R
|
Regions Financial Corp
F:RN7
|
US |
|
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
TH |
|
BluGlass Ltd
ASX:BLG
|
AU |
|
T
|
TISCO Financial Group PCL
SET:TISCO
|
TH |
|
Ragusa Minerals Ltd
ASX:RAS
|
AU |
|
Humana AB
STO:HUM
|
SE |
Bankruptcy Probability
Innate Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innate Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Innate Pharma SA
PAR:IPH
|
176m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innate Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innate Pharma SA has total debt of 13.8m EUR. This includes both short-term (0 EUR) and long-term (13.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
